Doheny Eye Center, UCLA

Pasadena, California 91105

1 studies enrolling now · 7 studies all time

What they study most

Age-Related Macular Degeneration, Geographic Atrophy, Glaucoma and Ocular Hypertension, Glaucoma, Angle-closure, Primary, Acute, Graves' Ophthalmopathy (GO), Leber Hereditary Optic Neuropathy, Macular Degeneration

Studies at this site

• Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
• Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy — Completed
• RESCUE and REVERSE Long-term Follow-up — Completed
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) — Stopped early
• Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG) — Completed